Results 141 to 150 of about 2,578,035 (249)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction. [PDF]

open access: yesBlood Adv
Rubinstein JD   +12 more
europepmc   +1 more source

Preclerkship Medical Students' Use of Third-Party Learning Resources.

open access: yesJAMA Netw Open, 2023
Lawrence ECN, Dine CJ, Kogan JR.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Across six societies children engage in costly third-party punishment of unfair sharing. [PDF]

open access: yesCommun Psychol
McAuliffe K   +10 more
europepmc   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari   +2 more
wiley   +1 more source

Third-party punishment-like behavior in a rat model. [PDF]

open access: yesSci Rep
Mikami K   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy